Clinical and radiological outcomes
| Variable | p-value | |
|---|---|---|
| Repeat embolization done, n (%) | 0 (0) | |
| Neurological improvement, n (%) | ||
| No change | 92 (34.2) | |
| Improve | 142 (52.8) | |
| Decline | 16 (5.9) | |
| Unknown | 19 (7.1) | |
| Follow-up mRS (median, IQR) | 1 (0,2) | |
| mRS change (median, IQR) | -1 (-1, 0) | <0.0001 |
| mRs improvement, n (%) | ||
| Improve | 115 (52.3) | |
| Same | 87 (39.5) | |
| Worse | 18 (8.2) | |
| Follow period, months (median, IQR) | 3 (1, 6.35) | |
| Clinical follow-up not available, n (%) | 46 (17.1) | |
| -SDH thickness at last follow-up, mm (median, IQR) | 9 (5, 14) | |
| -Change in SDH diameter at latest follow-up, mm (median, IQR) | 6 (2, 10.325) | <0.0001 |
| -Thickness decrease percentage (median, IQR) | 40.6% (15.7%, 62.5%) | |
| -SDH thickness improvement, n (%) | ||
| Improvement | 95 (81.9) | |
| Worsening | 14 (12.1) | |
| No Change* | 7 (6.0) | |
| -SDH thickness degree of improvement, n (%) | ||
| >20% improvement | 83 (71.6) | |
| >50% improvement | 43 (37.1) | |
| >70% improvement | 20 (17.2) | |
| >95% improvement | 3 (2.6) | |
| -Follow-up, months, (median, IQR) | 2 (1,5) | |
| Missing, n (%) | 153 (56.9) | |
* No change defined as a change of less than 0.25 mm